Profil bibliographique

Anne‐Claire Hardy‐Bessard

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

150Publications signalées

3756Citations signalées

1Affiliations récentes

Institutions déclarées

Imagerie Médicale et Radiothérapie Drôme Ardèche

Domaines associés

PARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancerCancer Treatment and PharmacologyBreast Cancer Treatment Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Final Results From the ATALANTE/ENGOT-ov29 Randomized Phase III Trial of Atezolizumab, Bevacizumab, and Platinum-Based Therapy for Late-Relapsing Recurrent Ovarian Cancer

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin, Lisa Belin et autres

0 citationsJCO oncology advances.

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Appendix S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Raphaël Leman, Etienne Müller, Angélina Legros, Nicolas Goardon et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.